Etiology and prevention of coronary obstructive lesions in infancy and childhood

Clinical Cardiology
|September 1, 1981
PubMed

Insights

Coronary atherosclerosis begins in infancy or even before birth, influenced by genetics and modifiable factors. Primary prevention strategies should commence in early childhood and pregnancy to mitigate risks.

Area of Science:

  • Cardiovascular Science
  • Pediatric Cardiology
  • Preventive Medicine

Background:

  • Coronary atherosclerosis is increasingly recognized as a condition originating in infancy or even embryonal life.
  • While genetic factors play a role, numerous environmental and lifestyle influences can modify disease development.
  • Nonatherosclerotic coronary obstructions can also manifest in infancy and childhood, often leading to severe health outcomes.

Purpose of the Study:

  • To emphasize the early onset of coronary atherosclerosis.
  • To highlight the importance of modifiable risk factors in disease development.
  • To advocate for early preventive interventions starting from pregnancy and early childhood.

Main Methods:

  • Review of established knowledge on the developmental origins of coronary atherosclerosis.
  • Analysis of genetic and environmental factors influencing coronary atherosclerosis.
  • Examination of nonatherosclerotic coronary obstructions in pediatric populations.

Main Results:

  • Coronary atherosclerosis has its roots in early life, including fetal development.
  • Modifiable factors present significant opportunities for primary prevention.
  • Early childhood and prenatal periods are critical windows for intervention.

Conclusions:

  • Primary prevention of coronary atherosclerosis is crucial and should be initiated early in life, including during pregnancy.
  • Addressing modifiable risk factors from infancy onwards can significantly impact long-term cardiovascular health.
  • Awareness and management of nonatherosclerotic coronary conditions in children are vital due to their severe potential consequences.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...